Chanichon Chomchoei

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Combination Therapy

Signaling Pathway

Induced Apoptosis

Top Venues

Expert opinion on therapeutic targets

This page only lists publications with an associated author ORCID identifier.

Publications

Chanichon Chomchoei, James Michael Brimson, Sirikalaya Brimson
Repurposing fluoxetine to treat lymphocytic leukemia: Apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction. Expert opinion on therapeutic targets 26 (12) (2023)
Chanichon Chomchoei, James Michael Brimson, Sirikalaya Brimson
Repurposing fluoxetine to treat lymphocytic leukemia: Apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction. Expert opinion on therapeutic targets 26 (12) (2023)
Chanichon Chomchoei, James Michael Brimson, Sirikalaya Brimson
Repurposing fluoxetine to treat lymphocytic leukemia: Apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction. Expert opinion on therapeutic targets 26 (12) (2023)
Chanichon Chomchoei, James Michael Brimson, Sirikalaya Brimson
Repurposing fluoxetine to treat lymphocytic leukemia: Apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction. Expert opinion on therapeutic targets (2023)
Chanichon Chomchoei, James Michael Brimson, Sirikalaya Brimson
Repurposing fluoxetine to treat lymphocytic leukaemia: Apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction. Expert opinion on therapeutic targets (2023)
Chanichon Chomchoei, James Michael Brimson, Sirikalaya Brimson
Repurposing fluoxetine to treat lymphocytic leukemia: Apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction. Expert opinion on therapeutic targets 26 (12) (2023)